Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timely IV Magnesium Sulfate in Moderate Asthma Exacerbation
NCT06137040Phase 1Recruiting
- Sponsor
- University of Oklahoma
- Start
- Nov 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of magnesium sulfate in asthma (2 arms), sponsored by University of Oklahoma. Primary endpoint: Change in Length of Stay in Patients who receive IV Magnesium within the first hour vs control group up to 1 week. Started Nov 2023; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06137040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06137040.